Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,384,042
  • Shares Outstanding, K 43,057
  • Annual Sales, $ 2,877 M
  • Annual Income, $ 1,195 M
  • EBIT $ 1,494 M
  • EBITDA $ 1,566 M
  • 60-Month Beta 0.85
  • Price/Sales 7.29
  • Price/Cash Flow 16.92
  • Price/Book 3.14

Options Overview Details

View History
  • Implied Volatility 49.62% (-0.96%)
  • Historical Volatility 18.15%
  • IV Percentile 86%
  • IV Rank 35.24%
  • IV High 92.62% on 08/25/25
  • IV Low 26.23% on 06/18/25
  • Expected Move (DTE 27) 50.11 (10.58%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 245
  • Volume Avg (30-Day) 609
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 26,292
  • Open Int (30-Day) 24,577
  • Expected Range 423.31 to 523.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 6.78
  • Number of Estimates 7
  • High Estimate 7.94
  • Low Estimate 5.79
  • Prior Year 6.19
  • Growth Rate Est. (year over year) +9.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
462.02 +2.47%
on 01/30/26
489.50 -3.28%
on 02/06/26
+5.35 (+1.14%)
since 01/20/26
3-Month
455.63 +3.90%
on 01/20/26
519.99 -8.96%
on 12/23/25
-1.30 (-0.27%)
since 11/20/25
52-Week
266.98 +77.32%
on 04/09/25
519.99 -8.96%
on 12/23/25
+106.06 (+28.87%)
since 02/20/25

Most Recent Stories

More News
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will report its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February...

UTHR : 473.42 (-1.48%)
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

UTHR : 473.42 (-1.48%)
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

UTHR : 473.42 (-1.48%)
United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure

This study was the world’s first FDA-cleared clinical trial using a bioengineered liver. Based on these positive results, United Therapeutics will initiate a phase 2 study ...

UTHR : 473.42 (-1.48%)
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that the company’s Board of Directors appointed Kevin J. Tracey, M.D., to...

UTHR : 473.42 (-1.48%)
3 Market-Beating Stocks to Target This Week

3 Market-Beating Stocks to Target This Week

KLAC : 1,496.00 (+1.78%)
SYF : 73.37 (+1.54%)
UTHR : 473.42 (-1.48%)
2 Cash-Heavy Stocks to Target This Week and 1 We Question

2 Cash-Heavy Stocks to Target This Week and 1 We Question

TCBI : 105.02 (+0.36%)
BRZE : 17.16 (+0.70%)
UTHR : 473.42 (-1.48%)
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Dr. Martine Rothblatt , Chairperson and Chief Executive Officer, will present a company overview and update...

UTHR : 473.42 (-1.48%)
2 Mooning Stocks on Our Buy List and 1 That Underwhelm

2 Mooning Stocks on Our Buy List and 1 That Underwhelm

CSCO : 79.20 (+0.81%)
UTHR : 473.42 (-1.48%)
HWM : 258.10 (+2.71%)
3 Market-Beating Stocks Worth Your Attention

3 Market-Beating Stocks Worth Your Attention

CECO : 78.78 (+0.69%)
RCL : 315.09 (+1.53%)
UTHR : 473.42 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 493.12
2nd Resistance Point 486.82
1st Resistance Point 480.12
Last Price 473.42
1st Support Level 467.12
2nd Support Level 460.82
3rd Support Level 454.12

See More

52-Week High 519.99
Last Price 473.42
Fibonacci 61.8% 423.34
Fibonacci 50% 393.48
Fibonacci 38.2% 363.63
52-Week Low 266.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar